400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Protein Tyrosine Kinase/RTK / EGFR & JAK & STAT / 酪氨酸激酶抑制剂AG 490
CAS No.: 133550-30-8
Synonyms: Tyrphostin AG490;Tyrphostin B42;Zinc02557947
AG-490 is a broad-spectrum inhibitor that has several targets including EGFR (IC50 = 2 μM), ErbB2 (IC50 = 13.5 μM), STAT3 and JAK2.
生物活性
靶点 | EGFR IC50:0.1μM |
实验方案
技术信息
CAS号 | 133550-30-8 | 储存条件 |
|
|||||||||||
分子式 | C17H14N2O3 | 运输 | 蓝冰 | |||||||||||
分子量 | 294.30 | 别名 | Tyrphostin AG490;Tyrphostin B42;Zinc02557947 | |||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
7TD1-DXM | 10 μM | Growth Inhibition Assay | 72 h | inhibits cell growth | 23871159 |
7TD1-DXM | 50 μM | Apoptosis Assay | 48 h | induces apoptosis | 23871159 |
7TD1-WD-90 | 10 μM | Growth Inhibition Assay | 72 h | inhibits cell growth | 23871159 |
7TD1-WD-90 | 50 μM | Apoptosis Assay | 48 h | induces apoptosis | 23871159 |
7TD1-WD-90 | 50 μM | Function Assay | 6 h | significantly inhibits the phosphorylation of JAK2 and phosphorylation of STAT3 | 23871159 |
A-172 | 50/100 μM | Function Assay | 48 h | reduces the levels of constitutively activated STAT3 in a time-dependent and dose-dependent fashion | 20589525 |
A-172 | 50/100 μM | Growth Inhibition Assay | 48 h | leads to a statistically significant reduction of cell proliferation over a time period of 48 h | 20589525 |
A-172 | 50/100 μM | Function Assay | 48 h | inhibits migration | 20589525 |
A-172 | 100 μM | Function Assay | 48 h | inhibits invasion | 20589525 |
A-172 | 50/100 μM | Function Assay | 48 h | reduces transcription of MMP genes and reduces enzymatic activity of MMPs | 20589525 |
A549 | 20/40 μM | Function Assay | 20 h | 20 μM AG490 suppresses the radiation-induced invasion of A549 cells | 23620191 |
A549 | 10/20/40 μM | Function Assay | 24 h | suppresses the radiation-induced elevation of VEGF | 23620191 |
A549 | 15 μm | Function Assay | 1 h | inhibits the phosphorylation of STAT1 on tyrosine 701 was detected 15 min after SPE B treatment | 19801665 |
AGS | 0-100 μM | Cell Viability Assay | 24/48/72 h | causes a significant reduction in cell viability dose-dependently but not time-dependently | 24151255 |
AGS | 50 μM | Function Assay | 24/48/72 h | the levels of pJAK2 began to decline at 24 hr, and rebounded at 72 hr | 24151255 |
AGS | 50 μM | Function Assay | 24/48/72 h | the cytoplasmic localization of pJAK2 (JAK2 phosphorylated at residues Tyr1007 and Tyr1008) decreased after AG490 treatment for 24 and 48 hr, but started to rebound at 72 hr | 24151255 |
ARPE-19 | 5 μM | Function Assay | 30 min | inhibits JAK2 phosphorilation | 21620963 |
B16-F0 | 50/100 µM | Function Assay | 48 h | reduces anoikis resistance | 25216522 |
BC3 | 100 µM | Function Assay | 24 h | mediates PEL cell apoptosis | 26184999 |
BC3 | 100 µM | Function Assay | 24 h | mediates de-phosphorylation of STAT3 correlated with HSP70 and HSF1 reduction | 26184999 |
BC3 | 100 µM | Function Assay | 24 h | induces a complete autophagic flux | 26184999 |
BCBL1 | 100 µM | Function Assay | 24 h | mediates PEL cell apoptosis | 26184999 |
BCBL1 | 100 µM | Function Assay | 24 h | mediates de-phosphorylation of STAT3 correlated with HSP70 and HSF2 reduction | 26184999 |
BCBL1 | 100 µM | Function Assay | 24 h | induces a complete autophagic flux | 26184999 |
BMMC | 0-10 μM | Function Assay | 15 min | inhibits LTC4 release in a dose-dependent fashion with near complete inhibition at concentrations ⩾10 μM | 19835845 |
BV-2 | 20 µM | Function Assay | 16 h | inhibits LPS-induced STAT1 phosphorylation with almost completely diminished iNOS expression | 23236370 |
EJ | 50/80 μM | Growth Inhibition Assay | 24/48/72 h | inhibits cell growth in both time and dose dependent manner | 24587049 |
EJ | 50/80 μM | Growth Inhibition Assay | 48 h | causes S-phase arrest | 24587049 |
EJ | 50/80 μM | Function Assay | 48 h | downregulates c-Myc, cyclinD1, survivin and VEGF expressions | 24587049 |
GL37 | 0-10 µM | Cell Viability Assay | 48 h | suppresses La expression | 24999657 |
HEL | 100 μM | Function Assay | 12-72 h | inhibits the level of p-JAK2, JAK2 | 20621061 |
HEL | 100 μM | Growth Inhibition Assay | 0-5 d | reduces growth of JAK2V617F-expressing HEL cells | 20621061 |
Hep-2 | 25-100 μM | Growth Inhibition Assay | 24/48/72 h | inhibits cell growth in both time and dose dependent manner | 21309481 |
Hep-2 | 50 μM | Apoptosis Assay | 24/48/72 h | induces cell apoptosis time dependently | 21309481 |
Hep-2 | 50 μM | Function Assay | 24/48/72 h | inhibits G1 to S cell cycle transition and induces G1 cell cycle arrest | 21309481 |
Hep-2 | 50 μM | Function Assay | 24/48/72 h | downregulates the STAT3, p-STAT3 and survivin protein levels | 21309481 |
HepG2 | 50-500 μM | Function Assay | 60 min | inhibits the IL-6-induced phosphorylation of STAT1 (Tyr705) and STAT3 (Tyr705) in a dose-dependent manner | 24242046 |
HepG2 | 100 μM | Function Assay | 12/24 h | inhibits STAT3 tyrosine phosphorylation | 23836400 |
HSC | 20 μM | Function Assay | 1 h | abrogates the differential effects of leptin or AGEs | 24614199 |
HSC-T6 | 10 μM | Apoptosis Assay | 2 h | inhibits the apoptosis of HSC-T6 cells induced by CDE | 21396998 |
HSC-T6 | 10 μM | Function Assay | 2 h | inhibits the expressions of pY-STAT1 and Bad induced by CDE | 21396998 |
HT29 | 100 µM | Function Assay | 24/48/72 h | decreases the expression of JAK2 and pJAK2 time-dependently | 22050790 |
HT29 | 100 µM | Function Assay | 24/48/72 h | decreases the pSTAT3 levels in a time-dependent manner | 22050790 |
HUVECs | 20 µM | Cell Viability Assay | 4 h | attenuates H2O2-induced cell shrinkage and improved the attachment rate of the cells | 23483946 |
HUVECs | 20 µM | Apoptosis Assay | 4 h | significantly decreases the cell apoptotic index | 23483946 |
Jurkat | 50 μM | Growth Inhibition Assay | 24/48/72 h | enhances TRAIL-induces cell growth inhibition | 19564891 |
Jurkat | 50 μM | Apoptosis Assay | 24/48 h | enhances TRAIL-induces cell apoptosis | 19564891 |
KF8 | 10 μM | Function Assay | 1 h | inhibits IL-33-induced NF-κB activation | 20940045 |
KF8 | 10 μM | Function Assay | 1 h | inhibits IL-33-induced IκBα degradation and NF-κB activation | 20940045 |
MC3T3-E1 | 50 μM | Function Assay | 4 h | inhibits HSE-induced BMP7 and GHR protein expression | 23877734 |
MeWo | 50/100 µM | Function Assay | 48 h | reduces anoikis resistance | 25216522 |
MZ-18 | 50/100 μM | Function Assay | 48 h | reduces the levels of constitutively activated STAT3 in a time-dependent and dose-dependent fashion | 20589525 |
MZ-18 | 50/100 μM | Growth Inhibition Assay | 48 h | leads to a statistically significant reduction of cell proliferation over a time period of 48 h | 20589525 |
MZ-18 | 50/100 μM | Function Assay | 48 h | inhibits migration | 20589525 |
MZ-18 | 100 μM | Function Assay | 48 h | inhibits invasion | 20589525 |
MZ-18 | 50/100 μM | Function Assay | 48 h | reduces transcription of MMP genes and reduces enzymatic activity of MMPs | 20589525 |
MZ-256 | 50/100 μM | Function Assay | 48 h | reduces the levels of constitutively activated STAT3 in a time-dependent and dose-dependent fashion | 20589525 |
MZ-256 | 50/100 μM | Growth Inhibition Assay | 48 h | leads to a statistically significant reduction of cell proliferation over a time period of 48 h | 20589525 |
MZ-256 | 50/100 μM | Function Assay | 48 h | inhibits migration | 20589525 |
MZ-256 | 100 μM | Function Assay | 48 h | inhibits invasion | 20589525 |
MZ-256 | 50/100 μM | Function Assay | 48 h | reduces transcription of MMP genes and reduces enzymatic activity of MMPs | 20589525 |
MZ-304 | 50/100 μM | Function Assay | 48 h | reduces the levels of constitutively activated STAT3 in a time-dependent and dose-dependent fashion | 20589525 |
MZ-304 | 50/100 μM | Growth Inhibition Assay | 48 h | leads to a statistically significant reduction of cell proliferation over a time period of 48 h | 20589525 |
MZ-304 | 50/100 μM | Function Assay | 48 h | inhibits migration | 20589525 |
MZ-304 | 100 μM | Function Assay | 48 h | inhibits invasion | 20589525 |
MZ-304 | 50/100 μM | Function Assay | 48 h | reduces transcription of MMP genes and reduces enzymatic activity of MMPs | 20589525 |
MZ-54 | 50/100 μM | Function Assay | 48 h | reduces the levels of constitutively activated STAT3 in a time-dependent and dose-dependent fashion | 20589525 |
MZ-54 | 50/100 μM | Growth Inhibition Assay | 48 h | leads to a statistically significant reduction of cell proliferation over a time period of 48 h | 20589525 |
MZ-54 | 50/100 μM | Function Assay | 48 h | inhibits migration | 20589525 |
MZ-54 | 100 μM | Function Assay | 48 h | inhibits invasion | 20589525 |
MZ-54 | 50/100 μM | Function Assay | 48 h | reduces transcription of MMP genes and reduces enzymatic activity of MMPs | 20589525 |
NRK-52E | 1 µM | Function Assay | 10 min | blocks the stimulatory effect of Ang II on Pax-2 expression | 24710423 |
NRK-52E | 1 µM | Function Assay | 10 min | blocks Ang II induced CD24 expression | 24710423 |
NRK-52E | 5 μM | Function Assay | 30 min | attenuates Ang-(1–7)-inhibited TGF-β1 mRNA at 16 h | 23174757 |
OVCAR-3 | 10 uM | Function Assay | 1 h | inhibits LPA-induced STAT3 phosphorylation | 19647363 |
OVCAR-3 | 10 uM | Function Assay | 1 h | inhibits LPA-induced ovarian cancer cell motility | 19647363 |
PA-1 | 10 uM | Function Assay | 1 h | inhibits LPA-induced STAT3 phosphorylation | 19647363 |
PA-1 | 10 uM | Function Assay | 1 h | inhibits LPA-induced ovarian cancer cell motility | 19647363 |
RAW264.7 | 50 μM | Function Assay | 24/48 h | suppresses RANKL-induced osteoclastogenesis | 23665018 |
RAW264.7 | 0-50 μM | Growth Inhibition Assay | 48 h | inhibits cell growth dose-dependently | 23665018 |
RAW264.7 | 0-50 μM | Growth Inhibition Assay | 48 h | causes an arrest of RAW264.7 cells at the G0/G1 phase of the cell cycle | 23665018 |
RAW264.7 | 50 μM | Function Assay | 24/48 h | inhibits RANKL-induced NFATc1 expression and phosphorylation of Ser727STAT3 | 23665018 |
RPE | 30 µM | Function Assay | 3 h | inhibits the induction of p-STAT3 expression | 23094067 |
SGC7901 | 0-100 μM | Cell Viability Assay | 24/48/72 h | causes a significant reduction in cell viability dose-dependently but not time-dependently | 24151255 |
SGC7901 | 50 μM | Function Assay | 24/48/72 h | the levels of pJAK2 began to decline at 24 hr, and rebounded at 72 hr | 24151255 |
SGC7901 | 50 μM | Function Assay | 24/48/72 h | the cytoplasmic localization of pJAK2 (JAK2 phosphorylated at residues Tyr1007 and Tyr1008) decreased after AG490 treatment for 24 and 48 hr, but started to rebound at 72 hr | 24151255 |
SK-MEL-2 | 50/100 µM | Function Assay | 48 h | reduces anoikis resistance | 25216522 |
SK-MEL-28 | 50/100 µM | Function Assay | 48 h | reduces anoikis resistance | 25216522 |
SK-MEL-5 | 50/100 µM | Function Assay | 48 h | reduces anoikis resistance | 25216522 |
SUPT1 | 50 μM | Growth Inhibition Assay | 24/48/72 h | enhances TRAIL-induces cell growth inhibition | 19564891 |
SUPT1 | 50 μM | Apoptosis Assay | 24/48 h | enhances TRAIL-induces cell apoptosis | 19564891 |
SW1116 | 100 µM | Function Assay | 24/48/72 h | decreases the expression of JAK2 and pJAK2 time-dependently | 22050790 |
SW1116 | 100 µM | Function Assay | 24/48/72 h | decreases the pSTAT3 levels in a time-dependent manner | 22050790 |
SW1990 | 20 μM | Growth Inhibition Assay | 24/48/72 h | inhibits cell growth time dependently | 20482858 |
SW1990 | 20 μM | Function Assay | 24 h | decreases the expression of MMP-2 and VEGF mRNAs | 20482858 |
SW1990 | 20 μM | Function Assay | 24 h | decreases the intensity of p-Stat3 expression | 20482858 |
SW1990 | 20 μM | Invasion Assay | 24 h | reduces invasion of SW1990 cells | 20482858 |
SW620 | 20 µM | Function Assay | 1/6 h | inhibits p-STAT3 activation | 23110625 |
THP1 | 10 uM | Function Assay | 30 min | inhibits STAT3 tyrosine phosphorylation by over 60% | 20393690 |
TRPM2/HEK | 0.1–25 µM | Function Assay | 15 min | reduces H2O2-induced Ca2+increase in a concentration-dependent manner, and the IC50 value was 1.7 µM | 25179574 |
TRPM2/HEK | 10 µM | Function Assay | 40 min | reduces TRPM2 activation even at high concentrations of H2O2 | 25179574 |
U937 | 0.1–25 µM | Function Assay | 15 min | reduces H2O2-induced Ca2+increase in a concentration-dependent manner, and the IC50 value was 0.4 µM | 25179574 |
靶点 | Description | IC50 |
---|---|---|
EGFR | IC50:0.1μM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网